CHURCHILL CAPITAL CORP-CL A
CCXINASDAQ🏆 #2940 by market capUS Equity
——
Quote unavailableTrack CCXI
Get earnings, price moves & breaking news on Telegram
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$429M
Small Cap
📈Revenue Growth (YoY)
0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
—
Insufficient data
No chart data available for CCXI.
Trading Snapshot
- Day Range
- —
- 52-Week Range
- $10.07 – $19.69
- Volume (shares)
- —
- Avg Volume (shares)
- —
- Shares Outstanding
- 41.9M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- —
- Last Q Revenue
- —
- P/E Ratio
- -4.2
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-2.41
- Dividend Yield
- 0.00%
CHURCHILL CAPITAL CORP-CL A
CCXIFinancial Trends
Financial history unavailable.
StockOtter · stockotter.spaceAbout CHURCHILL CAPITAL CORP-CL A
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.
Latest News & Updates
News unavailable.